Stockscreener 앱 받기
20.01
2.72%
-0.56
전일 마감가:
$20.57
열려 있는:
$20.64
하루 거래량:
600.48K
Relative Volume:
0.65
시가총액:
$1.03B
수익:
$312.78M
순이익/손실:
$-143.56M
주가수익비율:
-7.4387
EPS:
-2.69
순현금흐름:
$1.22M
1주 성능:
+16.81%
1개월 성능:
+3.36%
6개월 성능:
+4.22%
1년 성능:
-9.29%
1일 변동 폭
$19.95
$20.85
1주일 범위
$17.73
$21.20
52주 변동 폭
$10.96
$25.55
Caredx Inc Stock (CDNA) Company Profile
명칭
Caredx Inc
전화
415-287-2300
주소
8000 MARINA BLVD, BRISBANE, CA
CDNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
20.01 | 1.06B | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
618.72 | 234.69B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.99 | 169.45B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
715.37 | 56.86B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
237.68 | 41.09B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.64 | 41.06B | 6.95B | 1.30B | 1.15B | 4.5696 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-06 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2025-08-26 | 개시 | William Blair | Mkt Perform |
| 2025-01-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Underweight |
| 2024-08-19 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-05-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2023-11-09 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-03-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2023-03-03 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2021-07-20 | 재개 | BTIG Research | Buy |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-05 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-26 | 개시 | BTIG Research | Buy |
| 2020-06-19 | 재확인 | H.C. Wainwright | Buy |
| 2019-10-01 | 재개 | Craig Hallum | Buy |
| 2019-05-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | 개시 | Jefferies | Buy |
| 2018-10-23 | 재개 | Raymond James | Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Neutral |
| 2017-11-27 | 개시 | H.C. Wainwright | Buy |
| 2016-06-14 | 재확인 | Mizuho | Buy |
| 2015-09-29 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | 개시 | Craig Hallum | Buy |
| 2015-03-18 | 재확인 | Mizuho | Buy |
모두보기
Caredx Inc 주식(CDNA)의 최신 뉴스
Can CareDx Inc maintain sales growthJuly 2025 Short Interest & Expert Curated Trade Setups - bollywoodhelpline.com
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and CareDx (CDNA) - The Globe and Mail
Aug Levels: Is AEYE stock forming a triangle patternRate Hike & Precise Entry and Exit Recommendations - baoquankhu1.vn
Implied Volatility Surging for CareDx Stock Options - Yahoo Finance
CareDx (CDNA) Is Up 9.4% After Strong 2025 Outlook And 10x Genomics Tie-UpHas The Bull Case Changed? - Yahoo Finance
CareDx reports 25% revenue growth in Q4, expects $380 million for 2025 - Investing.com Canada
CareDx (NASDAQ:CDNA) Trading 15.3% HigherTime to Buy? - MarketBeat
Caredx Provides Earnings Guidance Fourth Quarter and Full Year 2025 - marketscreener.com
Aug Wrap: Is CareDx Inc a play on infrastructure spendingStop Loss & Weekly High Return Stock Forecasts - baoquankhu1.vn
CareDx Preliminary Q4 Revenue Up 25% - Nasdaq
CareDx reports 25% revenue growth in Q4, expects $380 million for 2025 By Investing.com - Investing.com South Africa
CareDx's prelim Q4 revenue beats estimates on higher testing volumes - TradingView — Track All Markets
Transplant test maker CareDx reports 25% jump in late‑2025 revenue - Stock Titan
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - The Joplin Globe
Profit Review: Can CareDx Inc stock continue upward trendJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn
Why CareDx Inc stock is popular among millennialsGap Down & Verified Chart Pattern Signals - Улправда
Aug Opening: Can CareDx Inc stock continue upward trendJuly 2025 Momentum & Fast Exit/Entry Strategy Plans - Улправда
Can CareDx Inc stock hit record highs again2025 Earnings Surprises & Daily Stock Momentum Reports - Улправда
Dow Update: Will CareDx Inc (1K9) stock gain from lower interest ratesJuly 2025 Macro Moves & AI Enhanced Trading Alerts - Улправда
Why retail investors pile into CareDx Inc stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - Улправда
Why CareDx Inc stock is in analyst buy zoneMarket Activity Summary & Verified Momentum Stock Ideas - ulpravda.ru
CareDx (NASDAQ:CDNA) Trading Down 7.9%What's Next? - MarketBeat
Can CareDx Inc stock continue upward trendShare Buyback & Entry Point Strategy Guides - ulpravda.ru
CareDx and 10x Genomics partner on transplant rejection research By Investing.com - Investing.com Nigeria
CareDx (CDNA) director Michael Goldberg receives 1,492-share equity grant - Stock Titan
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - BioSpace
Assessing CareDx (CDNA) Valuation After ImmuneScape Multiomics Collaboration With 10x Genomics - Sahm
CareDx, 10x Genomics Establish Multiomics Research Initiative - Contract Pharma
CareDx, 10x Genomics Launch Platform to Study Transplant Rejection and Drug Response - marketscreener.com
CareDx and 10x Genomics partner on transplant rejection research - Investing.com
CareDx, Inc. and 10x Genomics to Launch ImmuneScapeA Multiomics Research Platform to Decode Transplant Rejection and Drug Response - marketscreener.com
Oklahoma City NewsThe Oklahoman - FinancialContent
CareDx wins preliminary court approval for derivative settlement - MSN
CareDx (NASDAQ:CDNA) Shares Gap DownHere's Why - MarketBeat
Craig-Hallum downgrades CareDx stock rating to Hold from Buy By Investing.com - Investing.com South Africa
IBD rating upgrades: CareDx flashes improved technical strength - MSN
Craig-Hallum downgrades CareDx stock rating to Hold from Buy - Investing.com
What drives CareDx Inc 1K9 stock priceFinancial Sector Performance & Low Cost Investment Portfolio - earlytimes.in
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Eagle-Tribune
Should CareDx’s Governance Settlement and ESOP Shift Require Action From CareDx (CDNA) Investors? - simplywall.st
CareDx price target raised to $18 from $14 at Wells Fargo - MSN
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) (CDNA) - Seeking Alpha
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
CareDx (CDNA): Reassessing Valuation After Governance Reform Settlement and Legal Resolution Proposal - Sahm
CareDx (NASDAQ:CDNA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Will CareDx Inc stock benefit from commodity pricesShare Buyback & Capital Efficient Trade Techniques - Улправда
Short Covering: Why CareDx Inc stock is popular among millennialsJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - Улправда
Is CareDx Inc stock a bargain at current levels2025 Pullback Review & Entry and Exit Point Strategies - Улправда
Wells Fargo maintains CareDx (CDNA) equal-weight recommendation - MSN
Will CareDx Inc stock outperform Dow Jones index2025 Market Trends & High Win Rate Trade Alerts - Улправда
CareDx (NASDAQ: CDNA) secures preliminary approval for shareholder derivative settlement - Stock Titan
Caredx Inc (CDNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Caredx Inc 주식 (CDNA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Novack Jeffrey Adam | Secretary and General Counsel |
Dec 04 '25 |
Sale |
19.17 |
7,293 |
139,804 |
97,925 |
2.51%
0.74%
자본화:
|
볼륨(24시간):